VMG Global Cure Pte. Ltd.

VMG Global Cure Pte. Ltd. is a Singapore-incorporated consultancy that supports pharmaceutical and biotechnology sponsors through drug development and regulatory submission. Its public-facing service brand, DEWABET, is presented on the company's website as a provider of regulatory affairs and clinical trial consulting aligned with the expectations of the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and national authorities. The firm positions itself across the full development arc: scientific advice for CMC and non-clinical studies, clinical trial protocol design, and the drafting of submission dossiers such as IND, IMPD, PIP, ODD, and modules for MAA and NDA/BLA filings. It also offers pharmacovigilance documentation including RMP, DSUR, and PBRER, and says each file passes through gap analysis and quality control before submission, with pre-prepared responses to likely authority questions. For companies weighing licensing or investment, it advertises drug-asset due diligence. The website frames the value proposition around the cost of incomplete filings: it warns that incomplete submissions can delay clinical trials by months, that even drug candidates with strong data can stall at the regulator's desk if the dossier is not in order, and that each round of authority questions shifts study timelines and inflates budgets. The service flow is described as consultation, gap analysis, regulatory strategy, document preparation, and submission follow-up. Its stated clientele includes start-up biotechs, and the site is written in Indonesian, indicating a focus on Indonesian and wider Southeast Asian sponsors seeking FDA- and EMA-standard submissions. The DEWABET name also appears in the site's own text in connection with an unrelated online poker and card-game platform for Indonesian speakers, an apparent misuse or hijacking of the brand name on the same domain; the company's core identity remains pharmaceutical regulatory consulting. Corporate details such as founding year, founders, ownership, and executive leadership are not established by the available evidence and are left unstated here.

VMG Global Cure Pte. Ltd. is a Singapore private limited company whose public presence is built around its DEWABET pharmaceutical regulatory and clinical development consulting service. The available evidence does not record a founding date, founders, or corporate milestones. What is documented is the company's service model as presented on its website: it assists sponsors at every stage of drug development, from scientific advice for CMC and non-clinical studies through clinical trial protocol design to the writing of IND, IMPD, PIP, and ODD submissions and MAA and NDA/BLA modules. It also prepares pharmacovigilance documents such as RMP, DSUR, and PBRER, and offers due diligence on drug assets for companies considering licensing or investment. The company's messaging emphasizes the regulatory burden faced by sponsors: incomplete applications can delay clinical trials by months, and even candidates with strong data can be held up at the regulator if the dossier is not properly assembled. It notes that the FDA and EMA set strict formats and document orders, and that each round of authority questions shifts study schedules and increases budgets. To address this, VMG Global Cure describes a workflow of consultation, gap analysis, regulatory strategy, document preparation, and submission follow-up, with quality control and pre-prepared answers to likely authority questions before filing. The website is written in Indonesian and names start-up biotechs among its clients, indicating a focus on Indonesian and Southeast Asian sponsors seeking to meet FDA and EMA standards. The DEWABET name is also used on the same site in connection with an unrelated Indonesian-language online poker and card-game platform, which appears to be a misuse or hijacking of the brand name rather than part of the pharmaceutical consulting business. No ownership, leadership, or financial information is available in the evidence.

Regulatory and clinical development consultancy for pharmaceutical and biotech sponsors seeking FDA- and EMA-aligned submissions, with Indonesian-language outreach.

• Regulatory affairs consulting

  Scientific advice for CMC and non-clinical studies, regulatory strategy, and submission support.

• Clinical trial protocol design

  Design of clinical trial protocols for sponsors.

• IND / IMPD / PIP / ODD submission drafting

  Preparation of key regulatory submission documents.

• MAA and NDA/BLA module preparation

  Drafting of marketing authorization and new drug/biologics license application modules.

• Pharmacovigilance documents (RMP, DSUR, PBRER)

  Preparation of risk management plans, development safety update reports, and periodic benefit-risk evaluation reports.

• Drug asset due diligence

  Due diligence for companies considering licensing or investment.

1. 1DEWABET: Konsultan Pengembangan Farmasi & Uji Klinisvmgglobalcure.com
2. 2VMG GLOBAL CURE PTE. LTD.wikidata.org